胃部・胃食道接合部腺癌:世界の薬剤市場予測・分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 27
2.3 Upcoming Related Reports 27
3 Disease Overview 28
3.1 Etiology and Pathophysiology 28
3.1.1 Etiology 28
3.1.2 Pathophysiology 28
3.1.3 Biomarkers/Targets of Interest 30
3.2 Staging 31
3.3 Symptoms 33
3.4 Prognosis 33
3.5 Quality of Life 34
4 Epidemiology 36
4.1 Disease Background 36
4.2 Risk Factors and Comorbidities 37
4.3 Global Trends 38
4.3.1 8MM, Incidence Trends 39
4.4 Forecast Methodology 41
4.4.1 Sources Used 47
4.4.2 Sources Not Used 55
4.4.3 Forecast Assumptions and Methods, Diagnosed Incident Cases of Gastric Cancer – 8MM 56
4.4.4 Forecast Assumptions and Methods, Five-Year Diagnosed Prevalent Cases of Gastric Cancer – 8MM 57
4.4.5 Forecast Assumptions and Methods, Gastric Cancer Clinical Stages at Diagnosis – 8MM 58
4.4.6 Forecast Assumptions and Methods, Gastric Cancer Cellular Types – 8MM 59
4.4.7 Forecast Assumptions and Methods, HER2 Status – 8MM 61
4.4.8 Forecast Assumptions and Methods, Diagnosed Incident Cases of GEJ Cancer – 8MM 62
4.4.9 Forecast Assumptions and Methods, Diagnosed Incident Cases of Gastric Adenocarcinomas – 8MM 64
4.5 Epidemiological Forecast of Gastric Cancer (2014-2024) 64
4.5.1 Diagnosed Incident Cases of Gastric Cancer 64
4.5.2 Age-Specific Diagnosed Incident Cases of Gastric Cancer 66
4.5.3 Sex-Specific Diagnosed Incident Cases of Gastric Cancer 67
4.5.4 Age-Standardized Diagnosed Incidence of Gastric Cancer 69
4.5.5 Percentage Distribution of Diagnosed Incident Cases of Gastric Cancer, by Stage at Diagnosis 70
4.5.6 Percentage Distribution of Diagnosed Incident Cases of Gastric Cancer, by Cellular Type 71
4.5.7 Diagnosed Incident Cases of Gastric Cancer by HER2 Status 72
4.5.8 Diagnosed Incident Cases of GEJ Cancer 74
4.5.9 Five-Year Diagnosed Prevalent Cases of Gastric Cancer 76
4.6 Discussion 77
4.6.1 Epidemiological Forecast Insight 77
4.6.2 Limitations of the Analysis 78
4.6.3 Strengths of the Analysis 79
5 Disease Management 80
5.1 Diagnosis and Treatment Overview 80
5.1.1 Screening 80
5.1.2 Diagnosis 81
5.1.3 Treatment Guidelines and Leading Prescribed Drugs 85
5.1.4 Clinical Practice 85
5.2 US 96
5.2.1 Screening and Diagnosis 97
5.2.2 Clinical Practice 97
5.3 France 99
5.3.1 Screening and Diagnosis 100
5.3.2 Clinical Practice 101
5.4 Germany 101
5.4.1 Screening and Diagnosis 102
5.4.2 Clinical Practice 103
5.5 Italy 104
5.5.1 Screening and Diagnosis 105
5.5.2 Clinical Practice 105
5.6 Spain 106
5.6.1 Screening and Diagnosis 107
5.6.2 Clinical Practice 107
5.7 UK 108
5.7.1 Screening and Diagnosis 109
5.7.2 Clinical Practice 109
5.8 Japan 110
5.8.1 Screening and Diagnosis 111
5.8.2 Clinical Practice 113
5.9 China 118
5.9.1 Screening and Diagnosis 119
5.9.2 Clinical Practice 120
6 Competitive Assessment 125
6.1 Overview 125
6.2 HER2-Targeted Therapy 126
6.2.1 Herceptin (trastuzumab) 126
6.3 Angiogenesis Inhibitors 137
6.3.1 Cyramza (ramucirumab) 137
6.3.2 Aitan (apatinib) 149
6.4 Chemotherapies 155
6.4.1 TS-1 (tegafur, gimeracil, oteracil) 155
6.4.2 Abraxane (nab-paclitaxel) 166
7 Unmet Need and Opportunity 173
7.1 Overview 173
7.2 First-Line Therapy for HER2-Negative Patients 174
7.2.1 Unmet Need 174
7.2.2 Gap Analysis 175
7.2.3 Opportunity 176
7.3 New Molecular Targets for Targeted Therapies 176
7.3.1 Unmet Need 176
7.3.2 Gap Analysis 177
7.3.3 Opportunity 178
7.4 Effective Perioperative and Postoperative Therapies 181
7.4.1 Unmet Need 181
7.4.2 Gap Analysis 182
7.4.3 Opportunity 183
7.5 More Efficacious HER2-Targeted Therapies 184
7.5.1 Unmet Need 184
7.5.2 Gap Analysis 185
7.5.3 Opportunity 186
7.6 Peritoneal Metastases 187
7.6.1 Unmet Need 187
7.6.2 Gap Analysis 188
7.6.3 Opportunity 189
7.7 Better Clinical Trial Design 190
7.7.1 Unmet Need 190
7.7.2 Gap Analysis 190
7.7.3 Opportunity 191
7.8 Early Detection of Gastric and Gastroesophageal Adenocarcinomas 193
7.8.1 Unmet Need 193
7.8.2 Gap Analysis 194
7.8.3 Opportunity 195
8 Pipeline Assessment 196
8.1 Overview 196
8.2 Promising Drugs in Phase III Clinical Development 197
8.3 HER2-Targeted Therapies 198
8.3.1 Kadcyla (T-DM1; trastuzumab emtansine) 198
8.3.2 Perjeta (pertuzumab) 203
8.4 Immune Checkpoint Inhibitors 211
8.4.1 Keytruda (pembrolizumab) 211
8.4.2 Opdivo (nivolumab) 218
8.5 Further Strategies for G/GEJAC Treatment 224
8.5.1 Napabucasin 224
8.5.2 Lynparza (olaparib) 231
8.5.3 Nimotuzumab 239
8.5.4 TAS-118 247
8.6 Early/Near-Phase III Pipeline Drugs 252
8.6.1 GS-5745 252
8.6.2 Masitinib 256
8.7 Promising Drugs in Early-Stage Development 261
8.7.1 Immune Checkpoint Inhibitors 261
8.7.2 MET-Targeting Drugs 263
8.7.3 Antibody-Drug Conjugates 265
8.8 Biosimilars 269
9 Current and Future Players 272
9.1 Overview 272
9.2 Trends in Corporate Strategy 275
9.3 Company Profiles 276
9.3.1 Bristol-Myers Squibb 276
9.3.2 Eli Lilly and Company 279
9.3.3 Merck & Co. 282
9.3.4 Roche 285
9.3.5 Taiho Pharmaceutical 289
9.3.6 Sumitomo Dainippon Pharma 291
10 Market Outlook 294
10.1 Global Markets 294
10.1.1 Forecast 294
10.1.2 Drivers and Barriers – Global Issues 298
10.2 US 301
10.2.1 Forecast 301
10.2.2 Key Events 305
10.2.3 Drivers and Barriers – US 305
10.3 5EU 308
10.3.1 Forecast 308
10.3.2 Key Events 312
10.3.3 Drivers and Barriers – France 312
10.3.4 Drivers and Barriers – Germany 315
10.3.5 Drivers and Barriers – Italy 317
10.3.6 Drivers and Barriers – Spain 319
10.3.7 Drivers and Barriers – UK 321
10.4 Japan 324
10.4.1 Forecast 324
10.4.2 Key Events 328
10.4.3 Drivers and Barriers – Japan 328
10.5 China 331
10.5.1 Forecast 331
10.5.2 Key Events 335
10.5.3 Drivers and Barriers – China 335
11 Appendix 339
11.1 Bibliography 339
11.2 Abbreviations 374
11.3 Methodology 382
11.4 Forecasting Methodology 382
11.4.1 Diagnosed G/GEJAC Patients 382
11.4.2 Percent of Drug-Treated Patients 383
11.4.3 Drugs Included in Each Therapeutic Class 383
11.4.4 Launch and Patent Expiry Dates 384
11.4.5 General Pricing Assumptions 385
11.4.6 Individual Drug Assumptions 387
11.4.7 Generic Erosion 400
11.4.8 Pricing of Pipeline Agents 400
11.5 Primary Research – Key Opinion Leaders Interviewed for this Report 402
11.6 Primary Research – High-Prescriber Survey 405
11.7 About the Authors 406
11.7.1 Analyst 406
11.7.2 Therapy Area Director 406
11.7.3 Epidemiologist 407
11.7.4 Global Head of Healthcare 407
11.8 About GlobalData 408
11.9 Disclaimer 408


【レポート販売概要】

■ タイトル:胃部・胃食道接合部腺癌:世界の薬剤市場予測・分析
■ 英文:PharmaPoint: Gastric and Gastroesophageal Junction Adenocarcinoma - Global Drug Forecast and Market Analysis to 2024
■ 発行日:2015年12月
■ 調査会社:GlobalData
■ 商品コード:GDHC123PIDR
■ 調査対象地域:グローバル
  • 世界の微細藻燃料市場
    With the advances in technology, it has now become possible to generate fuel from even the trash that you throw out on a daily basis. One such novel innovations of technology in the recent years has been the capability to produce fuel from the common pond scum - or algae. In the last couple of years, algae has caught the interest of researchers worldwide because of its ability to be used as biofue …
  • 世界のモバイルヘルスケア(mHealth)市場
    With more than 7 Billion mobile network subscriptions worldwide, the mobile communications sector is rapidly gaining traction from a diverse range of vertical sectors. Healthcare is no exception to this trend. As healthcare providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost-efficiency. mHealt …
  • アジアの心臓律動管理(CRM)装置市場見通し
    Asia-Pacific Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the Asia-Pacific Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronis …
  • 高温断熱材の世界市場:セラミックファイバー、耐火断熱煉瓦
    About HTI Materials HTI products are used for application requiring high temperature, which is more than 1,000 c. The major function of HTI products is to conserve energy by reducing heat loss, controlling surface temperature, increasing operating efficiency of ventilation and reducing or preventing the damage of equipment. HTI products comprise of two major products: ceramic fiber and IFB. The ke …
  • 自動車用ブレーキオーバーライドシステムの世界市場:乗用車、商用車
    Global Automotive Brake Override System Market: About this market Brake override systems utilize a fail-safe technology that detects simultaneous applications of brake pedal and accelerator pedal and overlooks the acceleration command to avoid an accident. Technavio’s automotive brake override system market analysis considers sales from both passenger cars and commercial vehicles. Our analysis als …
  • Google Update April 2010
    The Google Update report provides timely analysis and projections about Google market prospects, products and applications, product and company integration, current and potential mergers and acquisitions, and more. Google Patent for Location-based Advertisements: One of the most important benefits of this edition of Google Update is a full analysis of the Google patent for location-based advertisi …
  • バックオフィス向けシステム統合ソリューションの世界市場
    About the Back Office System Integration MarketSystem integration solutions are used to integrate multiple systems, applications, and components in the information, communications, and technology (ICT) infrastructure of organizations. System integration solutions can be applied on the IT architecture of front office and back office to connect sub-systems and devices to exchange information within …
  • 世界のレンサ球菌検査市場
    The report presents a detailed analysis of the Streptococci diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Streptococci definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals     - Commercial/P …
  • フランスの心臓人工弁市場見通し(~2021)
    France Prosthetic Heart Valve Procedures Outlook to 2021 Summary GlobalData’s new report, "France Prosthetic Heart Valve Procedures Outlook to 2021", provides key procedures data on the France Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Hear …
  • 世界のデジタルメディアアダプター市場(2014-2018)
    TechNavio's analysts forecast the Global Digital Media Adaptor market to grow at a CAGR of 8.53 percent over the period 2013-2018. One of the key factors contributing to this market growth is the wireless streaming of media content. The Global Digital Media Adaptor market has also been witnessing the integration of digital media adapters. However, the growing STB market could pose a challenge to t …
  • 世界のエネルギー管理システム市場動向:エネルギー管理装置(スマートメーター、スマートサーモスタット、センサー)、エネルギー管理ソフトウェア
    The latest developments in the field of technology are allowing greater insight into energy procurement and energy usage. With the rising demand of power consumption and growing demand and supply gap, energy management systems are gaining worldwide popularity by identifying energy-saving opportunities. These systems reap long-term benefits by continually managing energy performance. With continuou …
  • 3Dモーションキャプチャーの世界市場予測(~2022)
    The 3D motion capture market is expected to reach USD 204.0 Million by 2022, at a CAGR of 10.28% during the forecast period. The innovations and new developments of 3D motion capture products in the market attributes to its high growth globally. 3D motion capture systems are being widely used for several applications such as media and entertainment, engineering & design and industrial, and biomech …
  • Endeavour International Corporation:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The r …
  • 世界のセキュリティソリューショング市場:提供別(製品(防火、ビデオ監視、アクセス制御)およびサービス(システム統合、リモート監視、防火、VSaaS、ACaaS))、業種別、地域別
    “The security solutions market is projected to grow at a CAGR of 9.0% from 2019 to 2024” The security solutions market was valued at USD 257.9 billion in 2019 and is projected to reach USD 397.6 billion by 2024; it is expected to grow at a CAGR of 9.0% during the forecast period. A few key factors driving the growth of this market include growing crime rates and terrorist activities globally, incr …
  • 防空・ミサイル防衛用レーダー(AMDR)の世界市場2016-2020
    About Air and Missile Defense Radar System AMDRs are devices that facilitate early detection of approaching aircraft or missiles so that necessary countermeasures can be taken. Air defense radars have a range of over 300 miles, and can detect missiles, locate their position, and determine their speed. The actual life cycle of an AMDR system is approximately 20 years. However, with midlife advancem …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。